The effect of carnitine supplementation in valproate-induced hyperammonaemia

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 4, 1996, Pages 446-449

  Bohles H ^a,c   Sewell, A C ^a   Wenzel, D ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Abt Padiatrische Hamatologie O   (Germany)

Author keywords

Carnitine; Carnitine insufficiency; Carnitine supplementation; Hyperammonaemia; Valproate

Indexed keywords

AMMONIA; CARNITINE; VALPROIC ACID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFECT; EPILEPSY; HUMAN; HYPERAMMONEMIA; PRIORITY JOURNAL;

EID: 0029925753     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14058.x     Document Type: Article

References (30)

1. Coulter DL, Allen RJ. Secondary hyperammonemia: a possible mechanism for valproate encephalopathy. Lancet 1980;i:1310
2. Böhles H, Richter K, Wagner-Thiessen E, Schäfer H. Decreased serum carnitine in valproate induced Reye syndrome. Eur J Pediatr 1982;139:185-9
3. Laub MC, Paetzke-Brunner I, Jaeger G. Serum carnitine during valproic acid therapy. Epilepsia 1986;27:559-62
4. Hug G, McGraw CA, Bates SR, Landrigan EA. Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin and carbamazepine in children. J Pediatr 1991;119:799-802
5. Ohtani Y, Endo F, Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 1982;101:782-5
6. McGarry JD, Foster DW. An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res 1976;17:277-81
7. Demirkol M, Sewell AC, Böhles H. The variation of carnitine content in human blood cells during disease - a study in bacterial infection and inflammatory bowel disease. Eur J Pediatr 1994;153:565-8
8. Wiedemann G, Haupt M, Rommel A, Rommel KF, Biesenbach R, Schmidt W. Incidence of pathologic ammonia concentrations in the plasma in children with seizure disorders treated with Convulsofin/Convulex and other anticonvulsants in comparison with children with brain damage and healthy children. Kinderarztl Prax 1990;58:21-7
9. Matsui K, Iwamoto H, Ohtsuki N, Kobayashi T, Miyake S, Yamada M. The problems of valproate therapy in severly handicapped children - valproate induced hyperammonemia and hypocarnitinemia. No-To-Hattatsu 1991;23:32-8
10. Thom H, Carter PE, Cole GF, Stevenson KL. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs. Dev Med Child Neurol 1991;33:795-802
11. Duarte J, Macias S, Fernandez E, Claveria LE. Valproate induced coma: case report and literature review. Ann Pharmacother 1993;27:582-3
12. Alonso E, Girbes J, Garcia-Espana A, Rubio V. Changes in urea cycle-related metabolites in the mouse after combined administration of valproic acid and an amino acid load. Arch Biochim Biophys 1989;272:267-73
13. Martin G, Michoudet C, Baverel G. Stimulation of glutamine metabolism by an antiepileptic drug, sodium valproate, in isolated dog kidney tubules. Biochem Pharmacol 1989;38:3947-52
14. Doval M, Culebras M, Lopez-Farre A, et al. Effect of valproate on lactate and glutamine metabolism by rat renal cortical tubules. Proc Soc Exp Biol Med 1989;190:357-64
15. Rumbach L, Cremel G, Warter JM, Waksman A. Valproate induced hyperammonemia of renal origin. Effects of valproate on glutamine transport in rat kidney mitochondria. Biochem Pharmacol 1989;38:3963-7
16. Kondo T, Ishida M, Kaneko S, et al. Is 2-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproate, responsible for valproate induced hyperammonemia? Epilepsia 1992;33:550-4
17. Osterloh J, Cunningham W, Dixon A, Combest D. Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes. Med Toxicol Adverse Drug Exp 1989;4:272-94
18. Murphy JV, Groover RV, Hodge C. Hepatotoxic effects in a child receiving valproate and carnitine. J Pediatr 1993;123:318-20
19. Murakami K, Sugimotot, Nishida N, Kobayashi Y, Kuhara T, Matsumoto I. Abnormal metabolism of carnitine and valproate in a case of acute encephalopathy during chronic valproate therapy. Brain Dev 1992;14:178-81.
20. Breum L, Astrup A, Gram L, et al. Metabolic changes during treatment with valproate in humans: implication for untoward weight gain. Metabolism 1992;41:666-70
21. Beghi E, Bizzi A, Codegoni AM, Trevisan D, Torri W. Valproate, carnitine metabolism, and biochemical indicators of liver function. Collaborative Group for the Study of Epilepsy. Epilepsia 1990;31:346-9
22. Melegh B, Kerner J, Acsadi G, Lakatos J, Sandor A. L-Carnitine replacement therapy in chronic valproate treatment. Neuropediatrics 1990;21:40-3
23. Melegh B, Kerner J, Jaszai V, Bieber LL. Differential excretion of xenobiotic acyl-esters of carnitine due to administration of pivampicillin and valproate. Biochem Met Metab Biol 1990;43:30-8
24. Thom H, Carter PE, Cole GF, Stevenson KL. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs. Dev Med Child Neurol 1991;33:795-802
25. Coulter DL. Carnitine, valproate and toxicity. J Child Neurol 1991;6:7-14
26. Matsuda I, Ohtani Y, Ninomiya N. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy. J Pediatr 1986;109:131-4.
27. Tein I, DiMauro S, Xie ZW, DeVivo DC. Valproic acid impairs carnitine uptake in cultured human skin fibroblasts. An in vitro model for the pathogenesis of valproic acid-associated carnitine deficiency. Pediatr Res 1993;34:281-7
28. Rozas I, Camina MF, Paz JM, Alonso C, Castro-Gago M, Rodriguez Segade S. Effects of acute valproate administration on carnitine metabolism in mouse serum and tissues. Biochem Pharmacol 1990;39:181-5
29. Sugimoto T, Nishida N, Murakami K, et al. Valproate-induced hepatotoxicity: protective effect of L-carnitine supplementation. Jpn J Psychiat Neurol 1990;44:387
30. Laub MC. Einfluß von Valproinsäurc auf Fettstoffwechsel und Carnitin. In Krämer G, Laub M editors. Berlin: Springer-Verlag, 225-36